This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Manohar Salla: Innovator in Phosphodiesterase Inhibitors
Introduction
Manohar Salla is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as phosphodiesterase inhibitors. His work is aimed at addressing various central nervous system diseases and inflammatory conditions.
Latest Patents
Manohar Salla holds a patent for "Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors." This invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7, and dual PDE type 4/PDE type 7 inhibitors. The compounds disclosed in this patent can be useful in the treatment, prevention, inhibition, or suppression of CNS diseases, such as multiple sclerosis. They also target various pathological conditions affecting the immune system, including AIDS and autoimmune disorders like rheumatoid arthritis. Additionally, the compounds are relevant for treating inflammatory diseases, gastrointestinal inflammation diseases, and different types of cancers, particularly in humans.
Career Highlights
Manohar Salla is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work has led to advancements in the treatment of complex diseases, showcasing his commitment to improving healthcare outcomes.
Collaborations
He has collaborated with notable coworkers, including Ritu Agarwal and Sunanda Ghosh Dastidar, contributing to a dynamic research environment that fosters innovation.
Conclusion
Manohar Salla's contributions to the field of phosphodiesterase inhibitors highlight his role as a key innovator in pharmaceuticals. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.